• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Advanced
search
ALL

Synonyms(0)

Find out more technical terms

Thesaurus Map Clips

ー



Please login to MyJ-GLOBAL to use J- GLOBAL.
Please register to create your MyJ-GLOBAL account, if you do not have one.
What is MyJ-GLOBAL?
Login Register now
Number of clips is over the max size. (Max number of Clips: 600)
Close
Reset
Go to 「How to search」 page
Advanced search: Search from
　
　Select basic information for advanced search
Free word
～
Chemical structure search
How to Search
NEW R FG i
C N O S F Cl Br I P X
JSME Molecular Editor by Peter Ertl and Bruno Bienfait
drag out MOL or RXN file
Import

MOLfile format is only available (V3000 format is not available)

              
Rchr
J-GLOBAL ID：200901071878902567   Update date: Mar. 27, 2025

Tanaka Toshihide

タナカ トシヒデ | Tanaka Toshihide
Affiliation and department：
Jikei University Faculty of Medicine, School of Medicine, Dept of Neurosurgery

About Jikei University Faculty of Medicine, School of Medicine, Dept of Neurosurgery


Job title： Associate Professor
Research field  (5)： Immunology ,  Cell biology ,  Tumor biology ,  Neurosurgery ,  Experimental pathology
Research keywords  (5)： 低浸襲な画像ガイド下脳神経外科手術と脳腫瘍手術に対する術中MRI ,  樹状細胞を基調とした脳腫瘍に対する免疫治療 ,  脳虚血と血管生物学 ,  脳腫瘍に対する遺伝子治療 ,  脳腫瘍病理と血管新生
Research theme for competitive and other funds  (15)：
  • 2025 - 2029 Identification of durational factors for therapeutic efficacy of bevacizumab focused on tumor microenvironment in glioblastoma
  • 2025 - 2026 免疫治療をした肺癌と脳転移同時発症例における原発巣・脳転移巣の腫瘍微小環境の比較
  • 2024 - 2025 悪性脳腫瘍に対する樹状細胞免疫治療と抗VEGF抗体併用療法における腫瘍微小環境の探索的研究
  • 2021 - 2025 Investigation of the effect and prediction factors of bevacizumab on immunoregulation in glioblastoma
  • 2023 - 2024 悪性神経膠腫に対するベバシズマブ術前化学療法の探索的研究:第二相臨床試験および病理組織学的解析
Show all
Papers (162)：
  • Jun Takei, Takayuki Inomata, Takuya Aoki, Shohei Nawate, Tatsuya Hirotsu, Keisuke Hatano, Mitsuyoshi Watanabe, Yasuto Noda, Masato Matsushima, Toshihiro Ishibashi, et al. Differences in neuroradiological impacts of hematoma volume and midline shift on clinical symptoms and recurrence rate in patients with unilateral chronic subdural hematoma. Journal of Clinical Neuroscience. 2025. 135. 111136-111136
  • Hiroaki Matsuzaki, Keitaro Kai, Yoshihiro Komohara, Hiromu Yano, Cheng Pan, Yukio Fujiwara, Rin Yamada, Ai Iwauchi, Nei Fukasawa, Toshihide Tanaka, et al. Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages. Cancer Science. 2025
  • Ai Iwauchi, Nei Fukasawa, Jun Takei, Miku Maeda, Kyoichi Tomoto, Akihiko Teshigawara, Yohei Yamamoto, Yasuharu Akasaki, Yuzuru Hasegawa, Yuichi Murayama, et al. Comparative analyses of erythroblast transformation specific-1 related gene expression before and after neoadjuvant bevacizumab therapy for newly diagnosed glioblastoma. Int J Clin Exp Pathol. 2024. 17. 10. 346-359
  • Rintaro Tachi, Michiyasu Fuga, Toshihide Tanaka, Akihiko Teshigawara, Ikki Kajiwara, Koreaki Irie, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama. The white-collar sign after Neuroform Atlas stent-assisted coil embolization of unruptured intracranial aneurysms. The Neuroradiology Journal. 2024
  • Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranari, Yasuharu Akasaki, et al. Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain Tumor Pathology. 2024
ｍore...
MISC (163)：
  • Toshihide Tanaka. Translational approach for brain tumors. 2025. 38-38
  • Akasaki Y., Takei J., Yamamoto Y., Teshigawara A., Tohmoto K., Koseki H., Tanaka T., Murayama Y. IMT-2 Translational research for a multicenter clinical trial of tumor-fused dendritic cell immunotherapy. Neuro-Oncology Advances. 2024. vol 6(suppl;6). vol 6(suppl;6). iv10-iv10
  • Tanaka T., Iwauchi A., Fukasawa N., Takei J., Teshigawara A., Tohmoto K., Yamamoto Y., Hasegawa Y., Akasaki Y., Shimoda M., et al. ANG-1 Trial of multi-omics analyses using paired samples from newly diagnosed and recurrent glioblastoma during bevacizumab therapy. Neuro-Oncology Advances. 2024. vol 6(suppl;6). vol 6(suppl;6). iv1-iv1
  • Yohei Yamamoto, Toshihide Tanaka, Akihiko Teshigawara, Takuya Ishii, Yasuharu Akasaki, Yuichi Murayama. 10031- MET-5 CHANGES IN PROGNOSTIC FACTORS IN PATIENTS WITH BRAIN METASTASES FROM LUNG CANCER. Neuro-Oncology Advances. 2024. 6. Supplement_4. iv20-iv21
  • Kyoichi Tomoto, Akihiko Teshigawara, Toshihide Tanaka, Yuzuru Hasegawa, Yuichi Murayama. 10040- STMO-2 ASSOCIATED FACTORS LEADING TO INTRAOPERATIVE HYPOTENSION DUE TO THE USE OF 5-AMINOLEVLINIC ACID. Neuro-Oncology Advances. 2024. 6. Supplement_4. iv11-iv11
ｍore...
Books (13)：
  • 脳腫瘍の化学療法, (3) Bevacizumab.
    日本臨床社(東京) 2023
  • 神経膠芽腫における腫瘍微小環境に関連したvascular endothelial growth factor (VEGF)による腫瘍血管新生と腫瘍免疫の調節
    実験医学・用土社 2019
  • Surgical wound management following craniotomy with attention to bevacizumab therapy
    2019 ISBN:9781536153354
  • Development and Perspectives of Histopathological Findings of Glioblastoma Treated by Bevacizumab
    2019 ISBN:9781536153354
  • 「わたしの手術記載」:若年性脳動静脈奇形(左前頭葉)
    (株)メジカルビュー社 2018
ｍore...
Lectures and oral presentations  (364)：
  • 術前ベバシズマブ投与後における膠芽腫摘出術の効用と課題
    (第34回日本脳神経外科CNTT学会 2025)
  • 肺癌原発・脳転移巣のペア標本を用いた免疫機構関連因子の比較解析
    (第43回日本脳腫瘍病理学会 2025)
  • 初再発膠芽腫のベバシズマブ治療前後でのペア標本の免疫学的腫瘍微小環境に対するマルチオミクス解析
    (第43回日本脳腫瘍病理学会 2025)
  • 脳血管内治療イラストで用いる”Digital Pen”作成
    (第9回日本メディカルイラストレーション学会学術集会 2025)
  • デジタル化時代における手術イラストを再考する〜デジタル使いとアナログ使いの語らい.
    (第9回日本メディカルイラストレーション学会学術集会 2025)
ｍore...
Works (2)：
  • 日本分子脳神経外科学会、ジュニア世話人
    2004 -
  • Improved method of protein delivery, composition and thereof -us patient
    1998 -
Education (2)：
  • 1993 - 1997 Jikei University Graduate School, Division of Medicine
  • 1985 - 1991 Jikei University Faculty of Medicine
Professional career (1)：
  • (BLANK) (Jikei University)
Work history (6)：
  • 2021/11 - 現在 Jikei University School of Medicine Department of Neurosurgery Associate Professor
  • 2009/09 - 2021/10 Jikei University School of Medicine Department of Neurosurgery
  • 1997/04 - 2009/08 Jikei University School of Medicine Department of Neurosurgery Instructor
  • 1994/01 - 1997/03 Harvard Medical School Dana-Farber Cancer Institute Research Associate
  • 1993/04 - 1993/12 Jikei University Division of Neuropathology, Neuroscience Institute postgraduate student
Show all
Committee career (8)：
  • 2025/01 - 現在 東京脳腫瘍研究会 世話人
  • 2024/11 - 現在 がんワクチン療法研究会 運営委員
  • 2024 - 現在 日本メディカルイラストレーション学会 理事
  • 2020 - 現在 Cellm001による初発膠芽腫治療効果無作為比較対照試験 画像中央判定委員
  • 2013 - 術中MRIガイドライン委員
Show all
Awards (3)：
  • 2022/12 - Japan Society for Neuro-Oncology Top Scoring Abstract award A prospective multicenter phase I/IIa study of prospective neoadjuvant bevacizumab for newly diagnosed glioblastoma
  • 1998/01 - アメリカ癌学会関連"血管新生と癌"Young Investigator Travel Awardee
  • 1997/04 - アメリカ癌学会 Young Investigator Award
Association Membership(s) (12)：
日本CI学会 ,  日本神経外傷学会 ,  日本癌学会 ,  Asian Conference of Neurological Surgeon ,  New York Academy of Science ,  日本血管細胞生物学学会 ,  日本遺伝子治療学会 ,  アメリカ癌学会 ,  日本脳神経外科学会 ,  日本脳腫瘍の外科学会 ,  日本メディカルイラストレーション学会 ,  Japan Society for Neuro-Oncology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM